Radiation plus immunotherapy: a new hope for melanoma?
NCT ID NCT02562625
First seen May 01, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tested whether adding radiotherapy to the drug pembrolizumab works better than pembrolizumab alone for people with advanced melanoma. The goal was to see if the combination could slow cancer growth and even shrink tumors that were not directly treated. The trial was stopped early and included 17 adults with stage III or IV melanoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Marsden
London, United Kingdom
Conditions
Explore the condition pages connected to this study.